GRx+Bosims 2023 to feature FDA Commissioner Robert Califf
FDA Commissioner Robert Califf will be the keynote FDA speaker during a “Fireside Chat” at GRx+Bosims 2023, which will be held Oct. 2-4.
Commissioner Califf holds a pivotal position as the senior official of the FDA, overseeing the review and approval of promising new medicines and medical therapies. His influential role makes him a leading and indispensable voice in shaping the future of the generic and biosimilars industries.
[Read more: AAM applauds Consolidated Appropriations Act of 2023]
In addition to his FDA experience, Califf has had an illustrious career in cardiovascular medicine and clinical research, including translational research that helped bridge scientific advancements to medical care.
[Read more: AAM applauds Consolidated Appropriations Act of 2023]
This event will be hosted by Interim David Gaugh, president and CEO of the Association for Accessible Medicines.
To register visit online here.
FDA Commissioner Robert Califf will be the keynote FDA speaker during a “Fireside Chat” at GRx+Bosims 2023, which will be held Oct. 2-4.
Commissioner Califf holds a pivotal position as the senior official of the FDA, overseeing the review and approval of promising new medicines and medical therapies. His influential role makes him a leading and indispensable voice in shaping the future of the generic and biosimilars industries.
[Read more: AAM applauds Consolidated Appropriations Act of 2023]
In addition to his FDA experience, Califf has had an illustrious career in cardiovascular medicine and clinical research, including translational research that helped bridge scientific advancements to medical care.
[Read more: AAM applauds Consolidated Appropriations Act of 2023]
This event will be hosted by Interim David Gaugh, president and CEO of the Association for Accessible Medicines.
To register visit online here.